市場調査レポート
商品コード
1066075

デジタルセラピューティクス/ウェルネス:主要動向、ビジネスモデル、市場予測 (2022年~2026年)

Digital Therapeutics & Wellness: Key Trends, Business Models & Market Forecasts 2022-2026

出版日: | 発行: Juniper Research Ltd | ページ情報: 英文 | 納期: 即日から翌営業日

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=195.32円
デジタルセラピューティクス/ウェルネス:主要動向、ビジネスモデル、市場予測 (2022年~2026年)
出版日: 2022年03月14日
発行: Juniper Research Ltd
ページ情報: 英文
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のデジタルセラピューティクスおよびデジタルウェルネスの市場について分析し、市場の基本構造・動向や機会・課題に関する戦略的分析、主な市場促進・抑制要因、主要企業のプロファイルと競合情勢、全体的な市場規模の動向見通し (利用者数・収益など、今後5年間分)、セグメント別の詳細動向、といった情報を取りまとめてお届けいたします。

目次

市場動向と戦略

第1章 重要なポイントと戦略提言

第2章 調査概要

  • イントロダクション
  • 定義
    • デジタルセラピューティクス (デジタル治療)
    • デジタルウェルネス
  • 調査範囲

第3章 市場力学

  • デジタルセラピューティクス
    • 医療提供と相互運用性の向上
    • 科学的検証と規制当局の承認
      • COVID-19による米国の規制緩和
    • 人工知能と機械学習
      • チャットボットの複雑さと「不気味の谷」
    • 慢性疾患の有病率の増加
  • デジタルウェルネス
    • コーポレートウェルネス
    • 市場のより幅広い魅力とメリット
    • 販売チャネルと多様化
    • ユーザーのプライバシーと信頼性

第4章 バリューチェーンとビジネスモデル

  • デジタルセラピューティクス
    • バリューチェーン
      • デジタルセラピューティクスのベンダー
      • システムインテグレーター
      • 保険当局
      • 臨床医と雇用者
      • 医療保険企業
      • エンドユーザー
    • ビジネスモデル
      • デジタルセラピューティクスのベンダー
      • システムインテグレーター
      • 医療保険企業
  • デジタルウェルネス
    • バリューチェーン
      • デジタルウェルネスのベンダー
      • 雇用者
      • 医療保険企業
      • 消費者
    • ビジネスモデル
      • デジタルウェルネスベンダー
      • 医療保険企業

競合リーダーボード

第1章 Juniper Researchのリーダーボード

第2章 ベンダーのプロファイル

  • 2Morrow
    • 企業概要
    • 各地域への進出状況
    • 主要顧客と戦略的パートナーシップ
    • 製品・サービスの概要
    • Juniper Researchの見解:主な強みと戦略的機会
  • Big Health
  • Click Therapeutics
  • Happify Health
  • Headspace Health
  • Kaia Health
  • Livongo
  • my mhealth
  • Omada Health
  • Pear Therapeutics
  • Sidekick Health
  • Vida Health
  • Voluntis
  • Wise Therapeutics
  • Welldoc

データと予測:目次

第1章 調査概要

第2章 市場概要:デジタルセラピューティクス/ウェルネス

  • 市場概要
    • デジタルセラピューティクス/ウェルネス製品の利用者数
    • デジタルセラピューティクス/ウェルネスの総収益

第3章 市場概要:デジタルセラピューティクス

  • イントロダクション
  • 調査手法と仮定
  • 市場の概要
    • デジタルセラピューティクスの利用者数
    • デジタルセラピューティクスの総収益
  • セグメント別の市場予測
    • 喘息・COPD
    • 心血管疾患 (CVD)・高血圧
    • 糖尿病
    • 理学療法
    • 禁煙
    • 体重管理

第4章 市場概要:デジタルウェルネス

  • イントロダクション
  • 調査手法と仮定
    • 消費者向けウェルネス
      • デジタルウェルネスアプリの利用者数
      • 使用中のデジタルウェルネスアプリの本数
      • サブスクリプションプランで収益化されているデジタルウェルネスアプリの本数
      • 消費者向けデジタルウェルネスの総収益
    • 企業向けウェルネス
      • 企業ウェルネスプログラムに登録している従業員の数
      • 企業向けウェルネスの総収益
  • 市場の概要
    • デジタルウェルネス製品の利用者数
    • デジタルウェルネスの総収益
  • セグメント別の市場予測
    • 消費者向けウェルネス
    • 企業向けウェルネス
目次

Juniper Research's “Digital Therapeutics & Wellness ” research includes a complete evaluation of the key drivers, trends, and challenges facing the digital therapeutics and wellness market. These are allied to a set of comprehensive 5-year forecasts and an in-depth assessment of the disruptive potential and market strategies of the leading digital therapeutics players.

The research suite includes:

  • 1. Market Trends & Strategies: Strategic analysis of key market dynamics and opportunities, together with a detailed analysis of the digital therapeutics and wellness value chain (PDF).
  • 2. Market Data & Forecasting: In-depth forecasts for market size and growth, including number of people using digital therapeutics, number of consumer wellness apps in use, number of employees enrolled in corporate wellness schemes, and total revenue (PDF).
  • 3. Competitor Leaderboard: Leading digital therapeutics vendors assessed and scored in our Competitor Leaderboard, underpinned by interviews with players and robust scoring methodologies (PDF).
  • 4. Interactive Forecast Excel: Highly granular dataset comprising more than 96,000 datapoints; allied to an Interactive Scenario tool; giving users the ability to manipulate Juniper Research's data (Interactive XL).
  • 5. harvest Online Data Platform: 12 months' access to the report's data in our online data platform, including continuous data updates and exportable charts, tables and graphs (Online).

Table of Contents

Market Trends & Strategies

1. Key Takeaways & Strategic Recommendations

  • 1.1 Digital Therapeutics
    • 1.1.1 Key Takeaways
    • 1.1.2 Strategic Recommendations
  • 1.2 Digital Wellness
    • 1.2.1 Key Takeaways
    • 1.2.2 Strategic Recommendations

2. Research Introduction

  • 2.1 Introduction
  • 2.2 Definitions
    • 2.2.1 Digital Therapeutics
    • 2.2.2 Digital Wellness
      • Figure 2.1: Segment Overlap of Digital Wellness and Digital Therapeutics
  • 2.3 Research Scope

3. Market Dynamics

  • 3.1 Digital Therapeutics
    • 3.1.1 Improved Healthcare Delivery & Interoperability
      • Figure 3.1: Number of People Using Digital Therapeutics (m), Split by 8 Key Regions, 2022-2026
    • 3.1.2 Scientific Validation & Regulatory Approval
      • i. Deregulation in the US Due to COVID-19
    • 3.1.3 Artificial Intelligence & Machine Learning
      • i. Chatbot Complexity & the Uncanny Valley
    • 3.1.4 Growing Prevalence of Chronic Conditions
      • Figure 3.2: Number of People Using Digital Therapeutics (m), Split by Addressed Condition, 2026
  • 3.2 Digital Wellness
    • 3.2.1 Corporate Wellness
    • 3.2.2 Wider Market Appeal & Benefits
      • Figure 3.3: Total Revenue from Corporate Wellness Programmes ($m), Split by Key 8 Regions, 2022-2026
    • 3.2.3 Sales Channels & Diversification
    • 3.2.4 User Privacy & Trust

4. Value Chain & Business Models

  • 4.1 Digital Therapeutics
    • 4.1.1 Value Chain
      • i. Digital Therapeutics Vendors
      • ii. Systems Integrators
      • iii. Health Regulators
      • iv. Clinicians and Employers
      • v. Health Insurers
      • vi. End Users
        • Figure 4.1: Digital Therapeutics Value Chain
    • 4.1.2 Business Models
      • i. Digital Therapeutics Vendors
        • Figure 4.2: Total Digital Therapeutics Revenue ($m), Split by Payer, 2026
      • ii. Systems Integrators
      • iii. Health Insurers
  • 4.2 Digital Wellness
    • 4.2.1 Value Chain
      • i. Digital Wellness Vendors
      • ii. Employers
      • iii. Health Insurers
      • iv. Consumers
        • Figure 4.3: Digital Wellness Value Chain
    • 4.2.2 Business Models
      • i. Digital Wellness Vendors
      • ii. Health Insurers

Competitor Leaderboard

1. Juniper Research Leaderboard

  • 1.1 Why Read This Report
    • Table 1.1: Juniper Research Leaderboard: Featured Vendors & Conditions Addressed by Product Portfolio
    • Figure 1.2: Juniper Research Leaderboard: Digital Therapeutics Vendors
    • Table 1.3: Juniper Research Leaderboard: Digital Therapeutics Vendor Positioning
    • Table 1.4: Juniper Research Leaderboard Heatmap: Digital Therapeutics Vendors
  • 1.2 Leaderboard Assessment Methodology
    • 1.2.1 Limitations & Interpretations

2. Vendor Profiles

  • 2.1 2Morrow
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
      • Figure 2.1: Advertisement for 2Morrow's Smoking Cessation Programme
    • iv. High-level View of Offerings
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.2 Big Health
    • i. Corporate
      • Table 2.2: Investor Funding Received by Big Health, 2014-2022
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 2.3: Sleepio UI
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.3 Click Therapeutics
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
      • Table 2.4: Investor Funding Received by Click Therapeutics, 2012-2021
    • iv. High-level View of Offerings
      • Table 2.5: Current Status of Click Therapeutics' Product Pipeline
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.4 Happify Health
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 2.6: Ensemble UI
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.5 Headspace Health
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 2.7: Headspace UI
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.6 Kaia Health
    • i. Corporate
      • Table 2.8: Investor Funding Received by Kaia Health, 2016-2021
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 2.9: Kaia MSK Therapy UI
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.7 Livongo
    • i. Corporate
      • Table 2.10: Teladoc Health Financial Snapshot ($m), FY 2019-2021 (FYE 31 December)
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
      • Figure 2.11: Livongo's AI+AI System
  • 2.8 my mhealth
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 2.12: myCOPD UI
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.9 Omada Health
    • i. Corporate
    • ii. Geographic Spread
      • Table 2.13: Investor Funding Received by Omada Health, 2011-2020
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 2.14: Omada Insights Lab
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.10 Pear Therapeutics
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Table 2.15: Current Status of Pear Therapeutics' Product Pipeline
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
      • Figure 2.16: reSET UI
  • 2.11 Sidekick Health
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.12 Vida Health
    • i. Corporate
    • ii. Geographic Spread
      • Table 2.17: Investor Funding Received by Vida Health, 2014-2021
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 2.18: Vida Health UI
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.13 Voluntis
    • i. Corporate
      • Table 2.19: Voluntis Financial Snapshot ($m), FY 2018-2020 (FYE 31 December)
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 2.20: Oleena UI
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.14 Wise Therapeutics
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 2.21: Personal Zen UI
      • Table 2.22: Wise Therapeutics' Current Product Pipeline
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 2.15 Welldoc
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
      • Figure 2.23: Bluestar for Diabetes UI

Data & Forecasting Table of Contents

1. Research Introduction

  • 1.1 Introduction
  • 1.2 Definitions
    • 1.2.1 Digital Therapeutics
    • 1.2.2 Digital Wellness
      • Figure 1.1: Segment Overlap of Digital Wellness and Digital Therapeutics
  • 1.3 Research Scope

2. Market Summary: Digital Therapeutics & Wellness

  • 2.1 Market Summary
    • 2.1.1 Number of People Using Digital Therapeutics & Wellness Products
      • Figure & Table 2.1: Number of People Using Digital Therapeutics & Wellness Products (m), Split by 8 Key Regions, 2021-2026
      • Table 2.2: Number of People Using Digital Therapeutics & Wellness Products (m), Split by Market, 2021-2026
      • Table 2.3: Number of People Using Digital Therapeutics & Wellness Products (m), Split by Business Model, 2021-2026
    • 2.1.2 Total Digital Therapeutics & Wellness Revenue
      • Figure 2.4: Total Digital Therapeutics & Wellness Revenue ($m), Split by 8 Key Regions, 2021-2026
      • Table 2.5: Total Digital Therapeutics & Wellness Revenue ($m), Split by Market, 2021-2026
      • Table 2.6: Total Digital Therapeutics & Wellness Revenue ($m), Split by Business Model, 2021-2026

3. Market Overview: Digital Therapeutics

  • 3.1 Introduction
  • 3.2 Methodology & Assumptions
    • 3.2.1 Number of People Using Digital Therapeutics
    • 3.2.2 Total Digital Therapeutics Revenue
      • Figure 3.1: Digital Therapeutics Forecast Methodology
  • 3.3 Market Summary
    • 3.3.1 Number of People Using Digital Therapeutics
      • Figure & Table 3.2: Number of People Using Digital Therapeutics (m), Split by 8 Key Regions, 2021-2026
    • 3.3.2 Total Digital Therapeutics Revenue
      • Figure & Table 3.3: Total Digital Therapeutics Revenue ($m), Split by 8 Key Regions, 2021-2026
      • Table 3.4: Total Digital Therapeutics Revenue ($m), Split by Payer, 2021-2026
  • 3.4 Segment Market Forecasts
    • 3.4.1 Asthma & COPD
      • i. Number of People Using Digital Therapeutics to Manage Asthma & COPD
        • Figure & Table 3.5: Number of People Using Digital Therapeutics to Manage Asthma & COPD (000's), Split by 8 Key Regions, 2021-2026
        • Table 3.6: Number of People Using Digital Therapeutics to Manage Asthma & COPD (000's), Split by Payer, 2021-2026
      • ii. Total Asthma & COPD Digital Therapeutics Revenue
        • Figure & Table 3.7: Total Asthma & COPD Digital Therapeutics Revenue ($m), Split by 8 Key Regions, 2021-2026
        • Table 3.8: Total Asthma & COPD Digital Therapeutics Revenue ($m), Split by Payer, 2021-2026
    • 3.4.2 CVD & Hypertension
      • i. Number of People Using Digital Therapeutics to Manage CVD & Hypertension
        • Figure & Table 3.9: Number of People Using Digital Therapeutics to Manage CVD & Hypertension (000's), Split by 8 Key Regions, 2021-2026
        • Table 3.10: Number of People Using Digital Therapeutics to Manage CVD & Hypertension (000's), Split by Payer, 2021-2026
      • ii. Total CVD & Hypertension Digital Therapeutics Revenue
        • Figure & Table 3.11: Total CVD & Hypertension Digital Therapeutics Revenue ($m), Split by 8 Key Regions, 2021-2026
        • Table 3.12: Total CVD & Hypertension Digital Therapeutics Revenue ($m), Split by Payer, 2021-2026
    • 3.4.3 Diabetes
      • i. Number of People Using Digital Therapeutics to Manage Diabetes
        • Figure & Table 3.13: Number of People Using Digital Therapeutics to Manage Diabetes (000's), Split by 8 Key Regions, 2021-2026
        • Table 3.14: Number of People Using Digital Therapeutics to Manage Diabetes (000's), Split by Payer, 2021-2026
      • ii. Total Diabetes Digital Therapeutics Revenue
        • Figure & Table 3.15: Total Diabetes Digital Therapeutics Revenue ($m), Split by Key Regions, 2021-2026
        • Table 3.16: Total Diabetes Digital Therapeutics Revenue ($m), Split by Payer, 2021-2026
    • 3.4.4 Physical Therapy
      • i. Number of People Who Receive Physical Therapy via Digital Therapeutics
        • Figure & Table 3.17: Number of People Who Receive Physical Therapy via Digital Therapeutics (000's), Split by 8 Key Regions, 2021-2026
        • Table 3.18: Number of People Who Receive Physical Therapy via Digital Therapeutics (000's), Split by Payer, 2021-2026
      • ii. Total Physical Therapy Digital Therapeutics Revenue
        • Figure & Table 3.19: Total Physical Therapy Digital Therapeutics Revenue ($m), Split by 8 Key Regions, 2021-2026
        • Table 3.20: Total Physical Therapy Digital Therapeutics Revenue ($m), Split by Payer, 2021-2026
    • 3.4.5 Smoking Cessation
      • i. Number of People Using Digital Therapeutics to Quit Smoking
        • Figure & Table 3.21: Number of People Using Digital Therapeutics to Quit Smoking (000's), Split by 8 Key Regions, 2021-2026
        • Table 3.22: Number of People Using Digital Therapeutics to Quit Smoking (000's), Split by Payer, 2021-2026
      • ii. Total Smoking Cessation Digital Therapeutics Revenue
        • Figure & Table 3.23: Total Smoking Cessation Digital Therapeutics Revenue ($m), Split by 8 Key Regions, 2021-2026
        • Table 3.24: Total Smoking Cessation Digital Therapeutics Revenue ($m), Split by Payer, 2021-2026
    • 3.4.6 Weight Management
      • i. Number of Obese or Overweight Adults Using Digital Therapeutics Manage Their Weight
        • Figure & Table 3.25: Number of Obese or Overweight Adults Using Digital Therapeutics to Manage Their Weight (000's), Split by 8 Key Regions, 2021-2026
        • Table 3.26: Number of Obese or Overweight Adults Using Digital Therapeutics Manage Their Weight (000's), Split by Payer, 2021-2026
      • ii. Total Weight Management Digital Therapeutics Revenue
        • Figure & Table 3.27: Total Weight Management Digital Therapeutics Revenue ($m), Split by 8 Key Regions, 2021-2026
        • Table 3.28: Total Weight Management Digital Therapeutics Revenue ($m), Split by Payer, 2021-2026

4. Market Overview: Digital Wellness

  • 4.1 Introduction
  • 4.2 Methodology & Assumptions
    • 4.2.1 Consumer Wellness
      • i. Number of People Using Digital Wellness Apps
      • ii. Number of Digital Wellness Apps in Use
      • iii. Number of Digital Wellness Apps That Are Monetised via Subscription Plans
      • iv. Total Consumer Digital Wellness Revenue
        • Figure 4.1: Consumer Digital Wellness Forecast Methodology
    • 4.2.2 Corporate Wellness
      • i. Number of Employees Enrolled in Corporate Wellness Programs
      • ii. Total Corporate Wellness Revenue
        • Figure 4.2: Corporate Digital Wellness Forecast Methodology
  • 4.3 Market Summary
    • 4.3.1 Number of People Using Digital Wellness Products
      • Figure & Table 4.3: Number of People Using Digital Wellness Products (m), Split by 8 Key Regions, 2021-2026
    • 4.3.2 Total Digital Wellness Revenue
      • Figure & Table 4.4: Total Digital Wellness Revenue ($m), Split by 8 Key Regions, 2021-2026
      • Table 4.5: Total Digital Wellness Revenue ($m), Split by Market Segment, 2021-2026
  • 4.4 Segment Market Forecasts
    • 4.4.1 Consumer Wellness
      • i. Number of People Using Digital Wellness Apps
        • Figure & Table 4.6: Number of People Using Digital Wellness Apps (m), Split by Key Regions, 2021-2026
      • ii. Number of Digital Wellness Apps in Use
        • Figure & Table 4.7: Number of Digital Wellness Apps in Use (m), Split by 8 Key Regions, 2021-2026
      • iii. Number of Digital Wellness Apps that Are Monetised via Subscription Plans
        • Figure & Table 4.8: Number of Digital Wellness Apps that Are Monetised via Subscription Plans (m), Split by 8 Key Regions, 2021-2026
      • iv. Total Consumer Digital Wellness Revenue
        • Figure & Table 4.9: Total Digital Wellness Revenue ($m), Split by 8 Key Regions, 2021-2026
    • 4.4.2 Corporate Wellness
      • i. Number of Employees Enrolled in Corporate Wellness Programmes
        • Figure & Table 4.10: Number of Employees Enrolled in Corporate Wellness Programmes (m), Split by 8 Key Regions, 2021-2026
      • ii. Total Corporate Digital Wellness Revenue
        • Figure & Table 4.11: Total Corporate Wellness Revenue ($m), Split by 8 Key Regions, 2021-2026